Lucid Diagnostics (LUCD) EBT Growth (3y) (2023 - 2026)
Lucid Diagnostics (LUCD) EBT Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | 4.82% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | -2.57% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 61.06% |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 32.11% |
| 10 | Lucid Diagnostics | 126.12 Mn | 98.24 Mn | -325,000.00 | 5.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.05% |
| Dec 31, 2025 | -2.90% |
| Sep 30, 2025 | 10.18% |
| Jun 30, 2025 | 32.79% |
| Mar 31, 2025 | -29.92% |
| Dec 31, 2024 | -0.69% |
| Sep 30, 2024 | -21.15% |
| Jun 30, 2024 | -21.32% |
| Mar 31, 2024 | -42.69% |
| Dec 31, 2023 | -58.28% |
| Sep 30, 2023 | -91.55% |